157 related articles for article (PubMed ID: 11208922)
41. Intense exercise increases circulating endocannabinoid and BDNF levels in humans--possible implications for reward and depression.
Heyman E; Gamelin FX; Goekint M; Piscitelli F; Roelands B; Leclair E; Di Marzo V; Meeusen R
Psychoneuroendocrinology; 2012 Jun; 37(6):844-51. PubMed ID: 22029953
[TBL] [Abstract][Full Text] [Related]
42. Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages.
Sun YX; Tsuboi K; Zhao LY; Okamoto Y; Lambert DM; Ueda N
Biochim Biophys Acta; 2005 Oct; 1736(3):211-20. PubMed ID: 16154384
[TBL] [Abstract][Full Text] [Related]
43. Mass-spectrometric identification of anandamide and 2-arachidonoylglycerol in nematodes.
Lehtonen M; Reisner K; Auriola S; Wong G; Callaway JC
Chem Biodivers; 2008 Nov; 5(11):2431-41. PubMed ID: 19035572
[TBL] [Abstract][Full Text] [Related]
44. Brain monoglyceride lipase participating in endocannabinoid inactivation.
Dinh TP; Carpenter D; Leslie FM; Freund TF; Katona I; Sensi SL; Kathuria S; Piomelli D
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10819-24. PubMed ID: 12136125
[TBL] [Abstract][Full Text] [Related]
45. Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide.
Jacobsson SO; Fowler CJ
Br J Pharmacol; 2001 Apr; 132(8):1743-54. PubMed ID: 11309246
[TBL] [Abstract][Full Text] [Related]
46. Hedonic eating is associated with increased peripheral levels of ghrelin and the endocannabinoid 2-arachidonoyl-glycerol in healthy humans: a pilot study.
Monteleone P; Piscitelli F; Scognamiglio P; Monteleone AM; Canestrelli B; Di Marzo V; Maj M
J Clin Endocrinol Metab; 2012 Jun; 97(6):E917-24. PubMed ID: 22442280
[TBL] [Abstract][Full Text] [Related]
47. Anandamide and other N-acylethanolamines in human tumors.
Schmid PC; Wold LE; Krebsbach RJ; Berdyshev EV; Schmid HH
Lipids; 2002 Sep; 37(9):907-12. PubMed ID: 12458627
[TBL] [Abstract][Full Text] [Related]
48. Identification of endocannabinoids and related compounds in human fat cells.
Gonthier MP; Hoareau L; Festy F; Matias I; Valenti M; Bès-Houtmann S; Rouch C; Robert-Da Silva C; Chesne S; Lefebvre d'Hellencourt C; Césari M; Di Marzo V; Roche R
Obesity (Silver Spring); 2007 Apr; 15(4):837-45. PubMed ID: 17426318
[TBL] [Abstract][Full Text] [Related]
49. Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.
Spoto B; Fezza F; Parlongo G; Battista N; Sgro' E; Gasperi V; Zoccali C; Maccarrone M
Biochimie; 2006 Dec; 88(12):1889-97. PubMed ID: 16949718
[TBL] [Abstract][Full Text] [Related]
50. Elevated endogenous cannabinoids in schizophrenia.
Leweke FM; Giuffrida A; Wurster U; Emrich HM; Piomelli D
Neuroreport; 1999 Jun; 10(8):1665-9. PubMed ID: 10501554
[TBL] [Abstract][Full Text] [Related]
51. A micro salting-out assisted liquid-liquid extraction combined with ultra-high performance liquid chromatography tandem mass spectrometry to determine anandamide and 2-arachidonoylglycerol in rat brain samples.
Oliveira IGC; Queiroz MEC
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov; 1158():122351. PubMed ID: 32882531
[TBL] [Abstract][Full Text] [Related]
52. Trick or treat from food endocannabinoids?
Di Marzo V; Sepe N; De Petrocellis L; Berger A; Crozier G; Fride E; Mechoulam R
Nature; 1998 Dec; 396(6712):636-7. PubMed ID: 9872309
[No Abstract] [Full Text] [Related]
53. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor.
Porter AC; Sauer JM; Knierman MD; Becker GW; Berna MJ; Bao J; Nomikos GG; Carter P; Bymaster FP; Leese AB; Felder CC
J Pharmacol Exp Ther; 2002 Jun; 301(3):1020-4. PubMed ID: 12023533
[TBL] [Abstract][Full Text] [Related]
54. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.
Melck D; De Petrocellis L; Orlando P; Bisogno T; Laezza C; Bifulco M; Di Marzo V
Endocrinology; 2000 Jan; 141(1):118-26. PubMed ID: 10614630
[TBL] [Abstract][Full Text] [Related]
55. In-tube solid-phase microextraction directly coupled to tandem mass spectrometry for anandamide and 2-arachidonoylglycerol determination in rat brain samples from an animal model of Parkinson's disease.
Oliveira IGC; Souza ID; Nascimento GCD; Del Bel E; Queiroz MEC
J Chromatogr A; 2021 Jan; 1636():461766. PubMed ID: 33316562
[TBL] [Abstract][Full Text] [Related]
56. Quantitative method for the profiling of the endocannabinoid metabolome by LC-atmospheric pressure chemical ionization-MS.
Williams J; Wood J; Pandarinathan L; Karanian DA; Bahr BA; Vouros P; Makriyannis A
Anal Chem; 2007 Aug; 79(15):5582-93. PubMed ID: 17600384
[TBL] [Abstract][Full Text] [Related]
57. Anandamide hydrolysis by human cells in culture and brain.
Maccarrone M; van der Stelt M; Rossi A; Veldink GA; Vliegenthart JF; Agrò AF
J Biol Chem; 1998 Nov; 273(48):32332-9. PubMed ID: 9822713
[TBL] [Abstract][Full Text] [Related]
58. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain.
Sugiura T; Kondo S; Sukagawa A; Nakane S; Shinoda A; Itoh K; Yamashita A; Waku K
Biochem Biophys Res Commun; 1995 Oct; 215(1):89-97. PubMed ID: 7575630
[TBL] [Abstract][Full Text] [Related]
59. Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina.
Bisogno T; Delton-Vandenbroucke I; Milone A; Lagarde M; Di Marzo V
Arch Biochem Biophys; 1999 Oct; 370(2):300-7. PubMed ID: 10577359
[TBL] [Abstract][Full Text] [Related]
60. Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy.
Citraro R; Russo E; Scicchitano F; van Rijn CM; Cosco D; Avagliano C; Russo R; D'Agostino G; Petrosino S; Guida F; Gatta L; van Luijtelaar G; Maione S; Di Marzo V; Calignano A; De Sarro G
Neuropharmacology; 2013 Jun; 69():115-26. PubMed ID: 23206503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
